MATTHEW WISE: Open Payments
NPI 1821689365 · KINGSTREE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 15 payments from 9 companies in 2025. Trend: 2023 $166 · 2024 $149 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $104 |
| Amgen Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Corcept Therapeutics | 1 | $14 |
Products named: Kerendia, OTEZLA, Ozempic, VOQUEZNA, GVOKE HYPOPEN, FARXIGA, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
